National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study

计划入组 22 人 · 首次发布于 2010 年 5 月 14 日

World Bleeding Disorders Registry

计划入组 20,000 人 · 首次发布于 2017 年 10 月 31 日

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

计划入组 300 人 · 首次发布于 2023 年 6 月 23 日

Bleeding disorders (Gubra)

PAR-1 antagonists (bleeding)

polyoma virus specific T cells

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

United States

NATIONAL INNOVATION FOUNDATION

India

Swiss National Science Foundation

Switzerland

BioMarin's ROCTAVIAN Gene Therapy Shows Sustained Efficacy After Five Years in Severe Hemophilia A

Hemophilia Gene Therapies Face Market Struggles Despite Scientific Promise

Hemab Therapeutics Secures $157 Million Series C to Advance First-in-Class Treatments for Rare Bleeding Disorders